Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.4950
-0.8250 (-62.50%)
Mar 16, 2026, 4:00 PM EDT - Market closed
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $878.57 thousand as of March 17, 2026. Its market cap has decreased by -93.73% in one year.
Market Cap
878.57K
Enterprise Value
10.20M
1-Year Change
-93.73%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $878.57K, a decrease of -99.62%. That is a compound annual growth rate of -61.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 878.57K | -83.93% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 2.64M |
| Enveric Biosciences | 2.64M |
| Azitra | 2.61M |
| BioRestorative Therapies | 2.59M |
| XORTX Therapeutics | 2.58M |
| HCW Biologics | 2.44M |
| Calidi Biotherapeutics | 2.28M |
| KALA BIO | 2.24M |